Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GPPAD-POInT: Oral Insulin for T1D Prevention
NCT03364868Phase 2Completed
- Sponsor
- Technical University of Munich
- Start
- Feb 2018
- Primary completion
- Jun 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 5
01
Overview
A Phase 2 trial of regular human insulin in type 1 diabetes mellitus (T1D), sponsored by Technical University of Munich. Started Feb 2018; status: completed.
02
Drugs
regular human insulin
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT03364868.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03364868.